AGF Investments Inc. boosted its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) by 697.2% in the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 90,130 shares of the medical research company’s stock after purchasing an additional 78,824 shares during the period. AGF Investments Inc.’s holdings in Thermo Fisher Scientific were worth $17,053,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also modified their holdings of the stock. Covington Capital Management lifted its holdings in Thermo Fisher Scientific by 0.9% during the 2nd quarter. Covington Capital Management now owns 2,144 shares of the medical research company’s stock worth $374,000 after buying an additional 20 shares during the last quarter. Investment Centers of America Inc. lifted its holdings in Thermo Fisher Scientific by 1.6% during the 2nd quarter. Investment Centers of America Inc. now owns 1,317 shares of the medical research company’s stock worth $230,000 after buying an additional 21 shares during the last quarter. Fort Washington Investment Advisors Inc. OH lifted its holdings in Thermo Fisher Scientific by 0.4% during the 2nd quarter. Fort Washington Investment Advisors Inc. OH now owns 6,250 shares of the medical research company’s stock worth $1,090,000 after buying an additional 23 shares during the last quarter. Bienville Capital Management LLC lifted its holdings in Thermo Fisher Scientific by 1.6% during the 2nd quarter. Bienville Capital Management LLC now owns 1,687 shares of the medical research company’s stock worth $295,000 after buying an additional 27 shares during the last quarter. Finally, Savant Capital LLC lifted its holdings in Thermo Fisher Scientific by 1.0% during the 2nd quarter. Savant Capital LLC now owns 2,793 shares of the medical research company’s stock worth $487,000 after buying an additional 29 shares during the last quarter. 86.16% of the stock is owned by hedge funds and other institutional investors.

In related news, CEO Marc N. Casper sold 50,000 shares of the firm’s stock in a transaction that occurred on Wednesday, November 15th. The stock was sold at an average price of $188.39, for a total value of $9,419,500.00. Following the sale, the chief executive officer now directly owns 252,577 shares in the company, valued at approximately $47,582,981.03. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.49% of the stock is currently owned by corporate insiders.

Shares of Thermo Fisher Scientific Inc. (TMO) remained flat at $$189.49 during trading on Wednesday. The company had a trading volume of 1,301,400 shares, compared to its average volume of 1,563,304. The company has a current ratio of 1.26, a quick ratio of 0.81 and a debt-to-equity ratio of 0.85. The firm has a market capitalization of $75,984.62, a price-to-earnings ratio of 20.82, a PEG ratio of 1.74 and a beta of 1.06. Thermo Fisher Scientific Inc. has a 12 month low of $139.88 and a 12 month high of $201.20.

Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings results on Wednesday, October 25th. The medical research company reported $2.31 earnings per share for the quarter, topping analysts’ consensus estimates of $2.24 by $0.07. The business had revenue of $5.12 billion for the quarter, compared to analysts’ expectations of $5.03 billion. Thermo Fisher Scientific had a return on equity of 15.94% and a net margin of 11.73%. The business’s quarterly revenue was up 13.9% on a year-over-year basis. During the same period in the prior year, the firm earned $2.03 EPS. equities research analysts predict that Thermo Fisher Scientific Inc. will post 9.36 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Monday, January 15th. Stockholders of record on Friday, December 15th will be given a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.32%. The ex-dividend date of this dividend is Thursday, December 14th. Thermo Fisher Scientific’s payout ratio is 10.19%.

A number of research firms have commented on TMO. Zacks Investment Research downgraded Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a report on Monday, September 18th. Barclays reaffirmed an “overweight” rating and set a $215.00 target price (up previously from $200.00) on shares of Thermo Fisher Scientific in a report on Monday, September 25th. Argus reaffirmed a “buy” rating on shares of Thermo Fisher Scientific in a report on Tuesday, August 22nd. They noted that the move was a valuation call. Jefferies Group reaffirmed a “hold” rating and set a $195.00 target price on shares of Thermo Fisher Scientific in a report on Thursday, September 28th. Finally, Morgan Stanley reaffirmed an “overweight” rating and set a $220.00 target price on shares of Thermo Fisher Scientific in a report on Wednesday, September 6th. One analyst has rated the stock with a hold rating and sixteen have issued a buy rating to the company. Thermo Fisher Scientific has a consensus rating of “Buy” and an average target price of $205.21.

COPYRIGHT VIOLATION WARNING: This article was first reported by Daily Political and is the property of of Daily Political. If you are accessing this article on another domain, it was illegally copied and reposted in violation of U.S. & international copyright & trademark law. The legal version of this article can be viewed at https://www.dailypolitical.com/2017/12/13/agf-investments-inc-has-17-05-million-position-in-thermo-fisher-scientific-inc-tmo.html.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.